LataMed AI LMED Income Statement (2023-2026)

OTC LMED
$0.44 +0.00 (+0.00%)
At close: Sep 3, 2026 · 4:00 PM EDT
Reported Financials

LataMed AI Quarterly Income Statement

Periods 12 quarters
Latest Mar 2026

LataMed AI reported net income of -$0.05M for the quarter ended Mar 2026. This income statement covers 12 quarters of results from Jun 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Selling, General & AdministrativeSG&A 0.00M2.93M-2.17M700.001.51M0.02M0.95M967.000.00M935.000.14M0.01M
Other Operating ExpensesOther Opex 0.01M0.01M0.04M0.03M0.01M0.01M0.03M0.01M0.01M0.03M-0.03M0.03M
Operating ExpensesOpex 0.01M2.94M-2.13M0.03M1.52M0.03M0.98M0.02M0.02M0.03M0.11M0.04M
Operating IncomeOp. Inc -0.01M-2.94M2.13M-0.03M-1.52M-0.03M-0.98M-0.02M-0.02M-0.03M-0.11M-0.04M
EBIT -0.01M-2.94M2.13M-0.03M-1.52M-0.03M-0.98M-0.02M-0.02M-0.03M-0.11M-0.04M
Non-operating items
Non Operating Interest Expenses 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Other Non Operating IncomeOther Non Op Inc. -0.01M0.00M-0.89M-0.01M-0.01M-0.01M0.10M-0.01M-0.01M-0.01M-0.01M-0.01M
Net income details
EBT -0.02M-2.94M1.24M-0.04M-1.53M-0.04M-0.92M-0.02M-0.03M-0.04M-0.12M-0.05M
Profit After TaxPAT -0.02M-2.94M1.24M-0.77M-1.53M-0.04M-0.92M-0.02M-0.03M-0.04M-0.12M-0.05M
Income from Continuing OperationsIncome (Continuing) -0.02M-2.94M1.24M-0.04M-1.53M-0.04M-0.92M-0.02M-0.03M-0.04M-0.12M-0.05M
Consolidated Net IncomeConsol Net Inc. -0.02M-2.94M1.24M-0.04M-1.53M-0.04M-0.92M-0.02M-0.03M-0.04M-0.12M-0.05M
Income towards Parent CompanyParent Net Inc -0.02M-2.94M1.24M-0.04M-1.53M-0.04M-0.92M-0.02M-0.03M-0.04M-0.12M-0.05M
Net Income towards Common StockholdersNet Income -0.02M-2.94M1.24M-0.04M-1.53M-0.04M-0.92M-0.02M-0.03M-0.04M-0.12M-0.05M
Additional items
EPS (Basic) 0.00-0.030.010.00-0.010.00-0.030.000.000.000.000.00
EPS (Diluted) 0.010.00-0.020.00-0.030.000.000.000.000.00
Shares Outstanding 85.63M85.63M85.63M85.63M109.63M109.63M29.28M29.28M29.28M29.28M32.65M56.13M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 88.92M88.92M88.92M88.92M29.28M29.28M29.28M29.28M29.28M29.28M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 85.63M85.63M109.63M109.63M29.28M29.28M29.28M29.28M32.65M56.13M
EBITDA -0.01M-2.94M2.13M-0.03M-1.52M-0.03M-0.98M-0.02M-0.02M-0.03M-0.11M-0.04M
Interest ExpensesInt Expense 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M